Arkolith/Insider Trading/ARTV/Form 4

Venbio Global Strategic GP III, Ltd

10% OwnerArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed Jul 22, 2024
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 22, 2024Conversion(C)844K——844K
Jul 22, 2024Other(J)462K——1.5M
Jul 22, 2024Buy(P)417K$12.00$5.0M1.9M
Jul 22, 2024Conversion(C)215K——1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 22, 2024Conversion(C)844K——0
Jul 22, 2024Conversion(C)215K——0

Transaction Codes

C
Conversion of a derivative
J
Other acquisition / disposition
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-001964) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML